HECTD3 promotes NLRP3 inflammasome and pyroptosis to exacerbate diabetes-related cognitive impairment by stabilising MALT1 to regulate JNK pathway

References

• Bagnall-Moreau, C., et al., 2019. Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Molecular neurobiology, 56 (10), 7159–7172.
   PubMed Web of Science ®Google Scholar
• Bai, H., and Zhang, Q., 2021. Activation of NLRP3 inflammasome and onset of Alzheimer’s disease. Frontiers in immunology, 12, 701282.
   PubMedGoogle Scholar
• Bai, T., et al., 2016. Diabetic cardiomyopathy: role of the E3 ubiquitin ligase. American journal of physiology. endocrinology and metabolism, 310 (7), E473–E483.
   PubMedGoogle Scholar
• Balaji, V., et al., 2018. Ubiquitylation pathways in insulin signaling and organismal homeostasis. BioEssays : news and reviews in molecular, cellular and developmental biology, 40 (5), e1700223.
   PubMed Web of Science ®Google Scholar
• Biessels, G.J., and Despa, F., 2018. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature reviews. endocrinology, 14 (10), 591–604.
   PubMed Web of Science ®Google Scholar
• Chen, Q., et al., 2017. Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats. Frontiers in Pharmacology, 8, 334–334.
   PubMedGoogle Scholar
• Cho, J.J., et al., 2019a. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation. Nature communications, 10 (1), 701.
   PubMedGoogle Scholar
• Cho, J.J., et al., 2019b. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation. Nature communications, 10 (1), 701.
   PubMedGoogle Scholar
• Chung, C.-C., et al., 2015. Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology, 85 (5), 450–458.
   PubMed Web of Science ®Google Scholar
• Corsa, C.A.S., et al., 2019. The E3 ubiquitin ligase parkin is dispensable for metabolic homeostasis in murine pancreatic β cells and adipocytes. The journal of biological chemistry, 294 (18), 7296–7307.
   PubMedGoogle Scholar
• Dempsey, C., et al., 2017. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Brain, behavior, and immunity, 61, 306–316.
   PubMed Web of Science ®Google Scholar
• Everson-Rose, S.A., and Ryan, J.P., 2015. Diabetes, obesity, and the brain: new developments in biobehavioral medicine. Psychosomatic medicine, 77 (6), 612–615.
   PubMedGoogle Scholar
• Gong, Y., et al., 2020. GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe/PS1dE9 mouse model of Alzheimer's disease. Neuropharmacology, 164, 107899.
   PubMed Web of Science ®Google Scholar
• Haneklaus, M., et al., 2013. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: Recent developments. Current opinion in immunology, 25 (1), 40–45.
   PubMed Web of Science ®Google Scholar
• He, J., et al., 2021. JNK inhibition alleviates delayed neurocognitive recovery after surgery by limiting microglia pyroptosis. International immunopharmacology, 99, 107962.
   PubMedGoogle Scholar
• Irrera, N., et al., 2020. The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. International journal of molecular sciences, 21 (17), 6204.
   Google Scholar
• Kim, E.J., et al., 2015. Stress effects on the hippocampus: a critical review. Learning and memory (Cold Spring Harbor, N.Y.), 22 (9), 411–416.
   PubMed Web of Science ®Google Scholar
• Knies, N., et al., 2015. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. Proceedings of the National Academy of Sciences of the United States of America, 112 (52), E7230–E7238.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., et al., 2021. A novel treatment strategy by natural products in nlrp3 inflammasome-mediated neuroinflammation in Alzheimer's and Parkinson's disease. International journal of molecular sciences, 22 (3), 1324.
   PubMedGoogle Scholar
• Li, F., et al., 2018. HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. The journal of clinical investigation, 128 (9), 4148–4162.
   PubMedGoogle Scholar
• Li, Y., et al., 2013. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8. Cell death and disease, 4 (11), e935-e935.
   Google Scholar
• Liu, F., et al., 2018. The role of NF-κB-mediated JNK pathway in cognitive impairment in a rat model of sleep apnea. Journal of thoracic disease, 10 (12), 6921–6931.
   PubMed Web of Science ®Google Scholar
• Liu, Y.W., et al., 2013. Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats. Psychopharmacology, 228 (4), 585–594.
   PubMed Web of Science ®Google Scholar
• Lourdes, O., et al., 2013. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Experimental gerontology, 48 (6), 565–571.
   PubMedGoogle Scholar
• McCrimmon, R.J., et al., 2012. Diabetes and cognitive dysfunction. The lancet, 379 (9833), 2291–2299.
   PubMed Web of Science ®Google Scholar
• Morimoto, N., et al., 2021. Inflammasomes in teleosts: structures and mechanisms that induce pyroptosis during bacterial infection. International journal of molecular sciences, 22 (9), 4389.
   PubMedGoogle Scholar
• Rajput, M.S., and Sarkar, P.D., 2017. Modulation of neuro-inflammatory condition, acetylcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice. Chemico-biological interactions, 268, 93–102.
   PubMed Web of Science ®Google Scholar
• Rangrez, A., et al., 2020. The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice. Communications biology, 3 (1), 562.
   PubMedGoogle Scholar
• Staal, J., et al., 2011a. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. The EMBO journal, 30 (9), 1742–1752.
   PubMed Web of Science ®Google Scholar
• Staal, J., et al., 2011b. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. The EMBO journal, 30 (9), 1742–1752.
   PubMed Web of Science ®Google Scholar
• Sui, X., et al., 2020. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo. Toxicology, 432, 152392.
   PubMedGoogle Scholar
• Turki, A., et al., 2013. Association of POL1, MALT1, MC4R, PHLPP and DSEL single nucleotide polymorphisms in chromosome 18q region with type 2 diabetes in Tunisians. Gene, 527 (1), 243–247.
   PubMedGoogle Scholar
• Umegaki, H., et al., 2013. Cognitive dysfunction: An emerging concept of a new diabetic complication in the elderly. Geriatrics and gerontology international, 13 (1), 28–34.
   PubMedGoogle Scholar
• Wang, B. N., et al., 2021. DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress. Acta pharmacologica sinica, 42 (3), 347–360.
   PubMedGoogle Scholar
• Wang, G., et al., 2022. Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c-JUN signaling pathway. Molecular medicine reports, 25 (4), 111.
   PubMedGoogle Scholar
• Wang, S-b., and Jia, J-p., 2014. Oxymatrine attenuates diabetes-associated cognitive deficits in rats. Acta pharmacologica sinica, 35 (3), 331–338.
   PubMedGoogle Scholar
• Wei, P., et al., 2019. The potential role of the NLRP3 inflammasome activation as a link between mitochondria ROS generation and neuroinflammation in postoperative cognitive dysfunction. Frontiers in cellular neuroscience, 13, 73.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2018. Novel insights into E3 ubiquitin ligase in cancer chemoresistance. The American journal of the medical sciences, 355 (4), 368–376.
   PubMedGoogle Scholar
• Yuan, W., et al., 2014. An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. Nature communications, 5, 5719–5719.
   PubMed Web of Science ®Google Scholar
• Zhao, L., et al., 2017. MeCP2 promotes gastric cancer progression through regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 signaling pathways. EBioMedicine, 16, 87–100.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., et al., 2015. E3 ubiquitin ligase Siah-1 downregulates synaptophysin expression under high glucose and hypoxia. American journal of translational research, 7 (1), 15–27.
   PubMedGoogle Scholar
• Zhou, R., et al., 2019. Recombinant CC16 inhibits NLRP3/caspase-1-induced pyroptosis through p38 MAPK and ERK signaling pathways in the brain of a neonatal rat model with sepsis. Journal of neuroinflammation, 16 (1), 239–239.
   PubMed Web of Science ®Google Scholar
• Zhou, W., et al., 2021. Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury. Cell death and disease, 12 (2), 211–211.
   PubMed Web of Science ®Google Scholar
• Zilliox, L.A., et al., 2016. Diabetes and cognitive impairment. Current diabetes reports, 16 (9), 1–11.
   PubMedGoogle Scholar